NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-494-2013-0-RU-12 Methods of Preparing Anti-human Papillomavirus Antigen T Cells RU DIV 2019105050 Issued
NIDA E-073-2013-0-US-09 POTENT AND SELECTIVE INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF US DIV 16/282,894 10913711 Issued PDF
NIBIB E-054-2018-0-PCT-02 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER PCT PCT PCT/US2019/019140 Expired
NIAID E-085-2018-0-PCT-02 CD153 AND/OR CD30 IN INFECTION PCT PCT PCT/US2019/019164 Expired
NIBIB E-054-2018-0-JP-10 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER JP National Stage 2020-543529 Pending
NIBIB E-054-2018-0-CN-03 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER CN National Stage 2019800148349 Pending
NIBIB E-054-2018-0-HK-12 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER HK CN 62020019110.9 Pending
NIBIB E-054-2018-0-EP-04 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER EP National Stage 19756548.4 Pending
NIBIB E-054-2018-0-KR-11 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER KR National Stage 2020-7027109 Pending
NIBIB E-054-2018-0-AU-08 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER AU National Stage 2019225154 Pending
NIBIB E-054-2018-0-IL-05 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER IL National Stage 276653 Pending
NIBIB E-054-2018-0-CA-09 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER CA National Stage 3090812 Pending
NIAID E-034-2018-0-PCT-01 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE PCT PCT COMB PCT/US2019/019021 Expired
NIAID E-034-2018-0-EP-05 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE EP National Stage 19709330.5 Pending
NIAID E-034-2018-0-CN-04 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE CN National Stage 201980025868.8 Pending
NIAID E-034-2018-0-CA-03 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE CA National Stage 3091437 Pending
NIAID E-034-2018-0-RU-07 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE RU National Stage 2020130795 Issued
NIAID E-034-2018-0-ZA-09 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE ZA National Stage 2020/05183 Pending
NIAID E-034-2018-0-IN-06 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE IN National Stage 2020037039570 Pending
NIAID E-034-2018-0-AU-02 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE AU National Stage 2019226034 Pending
NIBIB E-006-2016-0-US-04 SYSTEMS AND METHODS FOR INSTANT TOTAL INTERNAL REFLECTION FLUORESCENCE/ STRUCTURED ILLUMINATION MICROSCOPY US National Stage 16/326,757 1052-07-14 Issued PDF
NCATS E-020-2016-0-US-10 Antifungal Compound Process US DIV 16/280,534 10428025 Issued PDF
NCATS E-020-2016-0-US-09 Antifungal Compound Process US DIV 16/280,527 10407392 Issued PDF
NCATS E-262-2016-0-US-05 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINES AS IRAK-4 INHIBITORS US National Stage 16/326,571 11254667 Issued PDF
NHLBI E-064-2018-0-PCT-02 Inner Curvature Charge Concentration Device For Tissue Laceration PCT PCT PCT/US2019/018503 Expired
NIAID E-035-2018-0-PCT-01 TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS
TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIM 		PCT PCT COMB PCT/US2019/018606 Expired
NHLBI E-064-2018-0-EP-04 Inner Curvature Charge Concentration Device For Tissue Laceration EP National Stage 19756527.8 Pending
NHLBI E-064-2018-0-CN-03 Inner Curvature Charge Concentration Device For Tissue Laceration CN National Stage 201980008535.4 Pending
NIAID E-035-2018-0-HK-04 TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS
GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS 		HK EP 62021032425.2 Pending
NIAID E-035-2018-0-EP-02 TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS EP National Stage 19709243.0 Abandoned
NICHD E-120-2015-0-IL-58 Method For On-demand Contraception IL DIV 264867 Abandoned
NCI E-046-2019-0-AU-02 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging AU National Stage 2019222477 Issued
NCI E-046-2019-0-CH-08 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging CH EP 19711727.8 Issued
NCI E-046-2019-0-GB-11 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging GB EP 19711727.8 Issued
NCI E-046-2019-0-EP-04 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging EP National Stage 19711727.8 Issued
NCI E-046-2019-0-DE-09 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging DE EP 19711727.8 Issued
NCI E-046-2019-0-FR-10 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging FR EP 19711727.8 Issued
NCI E-046-2019-0-NL-12 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging NL EP 19711727.8 Issued
NCI E-046-2019-0-SE-13 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging SE EP 19711727.8 Issued
NCI E-046-2019-0-JP-05 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging JP National Stage 2020-543358 Issued
NCI E-046-2019-0-PCT-01 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging PCT PCT PCT/US2019/018153 Expired
NLM E-124-2017-1-US-03 METHODS FOR IDENTIFYING CLASS 2 CRISPR-CAS SYSTEMS US National Stage 16/326,132 Pending
NCI E-046-2019-0-CA-03 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging CA National Stage 3090797 Pending
NEI E-134-2016-0-US-07 SELECTIVE ESTROGEN-RECEPTOR MODULATORS (SERMS) CONFER PROTECTION AGAINST
PHOTORECEPTOR DEGENERATION 		US National Stage 16/325,678 11040019 Issued PDF
NCI E-036-2018-0-PCT-02 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS PCT PCT PCT/US2019/018057 Expired
NCI E-036-2018-0-EP-05 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS EP National Stage 19754834.0 Abandoned
NCI E-036-2018-0-JP-06 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS JP National Stage 2020-543808 Abandoned
NCI E-036-2018-0-CA-07 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS CA National Stage 3091423 Abandoned
NCI E-190-2014-0-EP-14 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		EP DIV 19156541.5 Issued
NIDDK E-028-2018-1-PCT-01 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS PCT PCT COMB PCT/US19/17422 Expired